HEATHER BLANCHETTE: Open Payments
NPI 1316936347 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,564 in 182 payments from 45 companies in 2025. Trend: 2023 $4,057 · 2024 $6,108 · 2025 $5,564
Food & beverage: $4,564Long term medical supply or device loan: $1,000
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 26 | $1,274 |
| Janssen Biotech, Inc. | 14 | $442 |
| AstraZeneca Pharmaceuticals LP | 12 | $300 |
| Daiichi Sankyo Inc. | 8 | $278 |
| PFIZER INC. | 12 | $244 |
| Merck Sharp & Dohme LLC | 11 | $226 |
| GlaxoSmithKline, LLC. | 8 | $193 |
| GENZYME CORPORATION | 6 | $191 |
| Celgene Corporation | 9 | $176 |
| Ipsen Biopharmaceuticals, Inc | 4 | $164 |
Products named: KISQALI, AYVAKIT, RYBREVANT, KEYTRUDA, DATROWAY, REBLOZYL, ENHERTU, SARCLISA.
Industry payments across FL — which companies pay providers there.
